WFA
KURA icon

Wipfli Financial Advisors’s Kura Oncology KURA Stock Holding History

Wipfli Financial Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$6K Buy
+424
New +$6.54K ﹤0.01% 2025

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wipfli Financial Advisors's KURA Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Kura Oncology (KURA) in Q3 2022: 424 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #2025 among its holdings.

148 funds tracked by Wall St. Rank hold KURA as of Q3 2022.

  • Wipfli Financial Advisors held 424 shares of Kura Oncology worth $6K as of Q3 2022.
  • Kura Oncology was a new Wipfli Financial Advisors position in Q3 2022.
  • Kura Oncology made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2025 holding.
  • 148 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.